Joint patent for using the BRCA1 gene as a therapy for cardiovascular disease

St. Michael's Hospital and King Saud University have received their first joint U.S. patent to use the BRCA1 gene as a therapy for cardiovascular disease.

Dr. Subodh Verma, a at St. Michael's, and Dr. Mohammed Al-Omran, a vascular surgeon at the largest university in Saudi Arabia, are named as inventors on patent US 8, 110,185 B2 issued Feb. 7.

Obtaining the patent is an initial step in realizing the potential of this innovative approach to treating one of the leading causes of death in Canada,

Dr. Verma's team published three papers in 2011, in Nature Communications, the and Gene Therapy, showing how the BRCA1 and 2 genes, which normally suppresses the growth of breast and ovarian tumours, also protect the heart.

Following a heart attack, mice with the mutated had a three-to-five times higher rate of death. This was largely due to the development of profound heart failure and poor DNA damage repair, leading to larger and more severe heart attacks.

Dr. Verma said the mutated BRCA1 gene may prevent in that is essential to recovery after a heart attack.

"The patent is also significant because it demonstrates how collaborative research between St. Michael's and King Saud University can help speed the transfer of medical discoveries from the laboratory bench to patient bedsides," said Dr. Arthur Slutsky, vice-president of research.

St. Michael's and King Saud jointly own the invention. The hospital has an agreement with the university and the inventors on how to share royalties. The hospital also has a commercialization partner, PARTEQ innovations, the technology transfer arm of Queen's University.

Provided by St. Michael's Hospital

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Enhanced DNA-repair mechanism can cause breast cancer

Oct 15, 2007

Although defects in the "breast cancer gene," BRCA1, have been known for years to increase the risk for breast cancer, exactly how it can lead to tumor growth has remained a mystery. In the October 15, 2007, issue of the ...

Recommended for you

Throwing a loop to silence gene expression

8 hours ago

All human cells contain essentially the same DNA sequence – their genetic information. How is it possible that shapes and functions of cells in the different parts of the body are so different? While every cell's DNA contains ...

A nucleotide change could initiate fragile X syndrome

Sep 01, 2014

Researchers reveal how the alteration of a single nucleotide—the basic building block of DNA—could initiate fragile X syndrome, the most common inherited form of intellectual disability. The study appears ...

Gene clues to glaucoma risk

Aug 31, 2014

Scientists on Sunday said they had identified six genetic variants linked to glaucoma, a discovery that should help earlier diagnosis and better treatment for this often-debilitating eye disease.

User comments